A cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospital

BACKGROUND: Cyclooxygenase-2 inhibitors (COX-2-Is) have recently been concerned in the occurrence of adverse cardiovascular (CV) events. Rofecoxib and valdecoxib has been withdrawn from the market, but celecoxib, etoricoxib and parecoxib continues to be used. Other nonsteroidal anti-inflammatory dru...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Bhosale, Uma A., Quraishi, Nilofar, Yegnanarayan, Radha, Devasthale, Dileep
التنسيق: Artigo
اللغة:Inglês
منشور في: Medknow Publications & Media Pvt Ltd 2014
الموضوعات:
Original Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4178340/
https://ncbi.nlm.nih.gov/pubmed/25298608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0300-1652.140386
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة